Training clinical providers in evidence-based hypnosis for cancer pain management
对临床提供者进行癌症疼痛管理循证催眠培训
基本信息
- 批准号:10597587
- 负责人:
- 金额:$ 32.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-13 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAcute pain managementAdoptionAdultAllyAmericanAmerican Society of Clinical OncologyAttitudeBehaviorBiologicalBone PainCancer Pain ManagementCancer PatientCancer SurvivorChronicChronic Cancer PainClinicalClinical CompetenceCognitiveCountryCultural SensitivityDegree programDiagnosisE-learningEducationEducational workshopEffectivenessEligibility DeterminationEmpathyEnrollmentEnsureEvaluationExerciseFeedbackFilmFutureGoalsGuidelinesHealthcare promotionHealthy People 2020HormonalHospitalizationHypnosisInterventionKnowledgeLearningLicensingLinkMalignant NeoplasmsMedicalMeta-AnalysisMethodsMind-Body InterventionMinorityMissionModalityMultimediaMusculoskeletal PainNational Comprehensive Cancer NetworkNeuropathyOperative Surgical ProceduresPainPain managementParticipantPatient Self-ReportPatientsPhasePlayPostoperative PainPreparationProfessional OrganizationsProgram EvaluationProviderPublishingQuality of CareQuality of lifeQuestionnairesRadiation therapyRadiodermatitisRecommendationRecording of previous eventsReportingResearchRoleSelf EfficacySiteSourceStandardizationSurveysSurvivorsTechniquesTerminal DiseaseTherapeuticThinkingTimeTrainingTraining Programsanticancer treatmentcancer carecancer paincancer therapycare providerschemotherapychronic painchronic pain managementclinical efficacyclinical practiceclinical trainingcohortcopingcost effectivecurative treatmentseffectiveness evaluationefficacious interventionevidence baseexperiencehealth care qualityhypnoticimprovedlecturesmind/bodyonline resourcepain reductionpharmacologicprogramspsychologicpsychosocialrecruitresearch clinical testingresponsesatisfactionskillssurvivorshipsymposiumsymptom managementtheoriestransfer learning
项目摘要
Rationale: In 2019, over 1.7 million Americans will be diagnosed with cancer. Among the innumerable rigors
associated with the diagnosis, perhaps the greatest source of suffering is pain. Pain can be associated with the
cancer itself, as well as with cancer treatments including. It is estimated that 39% of patients experience pain
following curative treatment, 55% during anticancer treatment, 40%of survivors experience pain,and 66% of
patients in advanced, metastatic, or terminal disease phases report pain. Unfortunately, approximately
third
are
one-
of patients with cancer-related pain are undertreated for that pain, and that the odds of undertreatment
twice as high for minorities Major cancer organizations have published pain management guidelines which.
recognize (e.g.,
hypnosis. The inclusion of hypnosis in these guidelines is based on a evidence
supporting the clinical efficacy of hypnosis for acute and chronic pain management. Meta-analysis has
the importance of integrating mind-body approaches ASCO, NCCN), among
long history of empirical
which is
indicated that on average 77%-95% of patients benefit from hypnotic pain management relative to control
participants. However, hypnosis training is not a standard component of either standard cancer provider
education or pain management training. As a result, this clinically efficacious intervention is rarely used by
providers to help patients in need. Objective: The goal of the proposed R25E is to train cancer care providers
in hypnosis to manage cancer pain. The Specific Aims are to: 1) Refine and implement a Hypnosis for Cancer
Pain (HCaP) training program; 2) Evaluate the effectiveness of the HCaP training on providers' knowledge,
skills, attitudes, and self-efficacy for using hypnosis to manage cancer pain; and, 3) Evaluate the impact of the
HCaP training program on trainees' real-world practice, using a mixed-methods approach. The HCaP training
content is guided by sociocognitive theory. Training will focus on the following domains: 1) Understanding
Cancer Pain; 2) Understanding Hypnosis; 3) Using Hypnosis for Cancer Pain Management; 4) Using Hypnosis
for Managing Symptoms, Thoughts, and Behaviors Associated with Pain; and, 5) Hypnosis Metacompetencies
(e.g., therapeutic alliance, empathy, cultural sensitivity). The evaluation plan for HCaP is guided by Miller's
pyramid of clinical competencies, and will focus on three levels of evaluation: Knowledge and Practical
Understanding, Skills, and Clinical Practice. Methods: Cancer care providers (N=400; including medical, allied,
and psychosocial providers) from across the country will be recruited via professional organizations, listservs,
and conferences. Trainees will participate in a blended training program including multimedia E-Learning and a
2-day live workshop, with evaluations linked to each modality. Trainees will also be evaluated at 3 months
following the workshop. Long-term goals: The proposed R25E is a critical first step toward improving quality of
care and quality of life for cancer patients in pain. Connection to NCI mission: This project is consistent with the
Healthy People 2020 goal of improving quality of life of cancer patients and survivors.
理由:2019 年,超过 170 万美国人将被诊断出患有癌症。在无数的严酷考验中
与诊断相关,也许最大的痛苦来源是疼痛。疼痛可能与
癌症本身,以及癌症治疗。据估计 39% 的患者会经历疼痛
在治愈性治疗后,55% 的幸存者在抗癌治疗期间,40% 的幸存者经历疼痛,66%
处于晚期、转移性或末期疾病阶段的患者报告有疼痛。不幸的是,大约
第三
是
一-
患有癌症相关疼痛的患者没有得到充分治疗,并且治疗不足的几率
少数族裔的发病率是其两倍 主要癌症组织已发布疼痛管理指南。
认识(例如,
催眠。将催眠纳入这些指南是基于以下证据:
支持催眠治疗急性和慢性疼痛的临床疗效。荟萃分析有
整合身心方法的重要性(ASCO、NCCN),其中
经验主义的悠久历史
这是
表明相对于控制,平均 77%-95% 的患者从催眠疼痛管理中受益
参与者。然而,催眠训练并不是标准癌症提供者的标准组成部分
教育或疼痛管理培训。因此,这种临床上有效的干预措施很少被使用
提供者帮助有需要的患者。目标:拟议 R25E 的目标是培训癌症护理提供者
通过催眠来控制癌症疼痛。具体目标是: 1) 完善和实施癌症催眠术
疼痛(HCaP)培训计划; 2) 评估 HCaP 培训对提供者知识的有效性,
使用催眠治疗癌症疼痛的技能、态度和自我效能; 3) 评估影响
HCaP 培训计划针对学员的实际实践,采用混合方法。 HCaP 培训
内容以社会认知理论为指导。培训将重点关注以下领域: 1) 理解
癌症疼痛; 2)了解催眠; 3)使用催眠治疗癌症疼痛; 4)使用催眠
用于管理与疼痛相关的症状、想法和行为;以及,5) 催眠元能力
(例如,治疗联盟、同理心、文化敏感性)。 HCaP 的评估计划以 Miller 的指导
临床能力金字塔,将侧重于三个层次的评估:知识和实践
理解、技能和临床实践。方法:癌症护理提供者(N=400;包括医疗、联合、
来自全国各地的社会心理服务提供者)将通过专业组织、列表服务器、
和会议。学员将参加混合培训计划,包括多媒体电子学习和
为期 2 天的现场研讨会,评估与每种模式相关。学员还将在三个月后接受评估
研讨会结束后。长期目标:拟议的 R25E 是提高质量的关键第一步
疼痛中的癌症患者的护理和生活质量。与 NCI 任务的联系:该项目与
Healthy People 2020 的目标是提高癌症患者和幸存者的生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guy H Montgomery其他文献
Guy H Montgomery的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guy H Montgomery', 18)}}的其他基金
Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health
通过告知女性乳腺癌和乳腺动脉钙化结果,增强乳房 X 光检查的公共健康益处:一项促进心血管健康的随机试验
- 批准号:
10380781 - 财政年份:2022
- 资助金额:
$ 32.34万 - 项目类别:
Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health
通过告知女性乳腺癌和乳腺动脉钙化结果,增强乳房 X 光检查的公共健康益处:一项促进心血管健康的随机试验
- 批准号:
10634705 - 财政年份:2022
- 资助金额:
$ 32.34万 - 项目类别:
Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health
通过告知女性乳腺癌和乳腺动脉钙化结果,增强乳房 X 光检查的公共健康益处:一项促进心血管健康的随机试验
- 批准号:
10211939 - 财政年份:2021
- 资助金额:
$ 32.34万 - 项目类别:
Training Program in Cancer Prevention and Control for Priority Populations
重点人群癌症预防和控制培训项目
- 批准号:
10238055 - 财政年份:2018
- 资助金额:
$ 32.34万 - 项目类别:
Training Program in Cancer Prevention and Control for Priority Populations
重点人群癌症预防和控制培训项目
- 批准号:
9789853 - 财政年份:2018
- 资助金额:
$ 32.34万 - 项目类别:
Training Program in Cancer Prevention and Control for Priority Populations
重点人群癌症预防和控制培训项目
- 批准号:
10628864 - 财政年份:2018
- 资助金额:
$ 32.34万 - 项目类别:
Training Program in Cancer Prevention and Control for Priority Populations
重点人群癌症预防和控制培训项目
- 批准号:
10469343 - 财政年份:2018
- 资助金额:
$ 32.34万 - 项目类别:
Training providers in CBT plus Hypnosis - an evidence-based fatigue intervention
CBT 加催眠培训提供者 - 一种基于证据的疲劳干预措施
- 批准号:
8997819 - 财政年份:2015
- 资助金额:
$ 32.34万 - 项目类别:
Training providers in CBT plus Hypnosis - an evidence-based fatigue intervention
CBT 加催眠培训提供者 - 一种基于证据的疲劳干预措施
- 批准号:
9769650 - 财政年份:2015
- 资助金额:
$ 32.34万 - 项目类别:
Training providers in CBT plus Hypnosis - an evidence-based fatigue intervention
CBT 加催眠培训提供者 - 一种基于证据的疲劳干预措施
- 批准号:
9148261 - 财政年份:2015
- 资助金额:
$ 32.34万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Miniscope in vivo imaging of cumulative traumatic brain injury
累积性脑外伤的微型活体成像
- 批准号:
10648962 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
PediQUEST ResPOND: Piloting an intervention to treat recurrent pain in children with severe neurological impairment
PediQUEST ResPOND:试点干预措施治疗严重神经损伤儿童的复发性疼痛
- 批准号:
10606777 - 财政年份:2023
- 资助金额:
$ 32.34万 - 项目类别:
Intrinsic Efficacy as a Determinant of Opioid Effectiveness in Treatment of Pain-Depressed Behavior
内在功效是阿片类药物治疗疼痛抑郁行为有效性的决定因素
- 批准号:
10389903 - 财政年份:2022
- 资助金额:
$ 32.34万 - 项目类别: